AMSA Pharm-free Scorecard 2010
A Stony Brook University School of Medicine
City: Stony Brook State: NY
Links:
Commentary:

Summary: Stony Brook University School of Medicine submitted new policies after the submission deadline for the 2011-12 AMSA PharmFree Scorecard. This new policy is very strong in managing the relationship between industry and faculty. It sets strict guidelines for gifts, meals, as well as faculty involvement in speakers' bureaus. Additionally, disclosure must be made public with a templated format during all lectures. Pharmaceutical sales representatives are not allowed in patient areas and must have a prior appointment. On and off-site education policies are also very strong as for on-site education, industry funds are allowed into a centralized pool and faculty are not allowed to attend off-site education events that are sponsored by the pharmaceutical industry. Similarly, scholarship and trainee funds from industry must be given to a centralized office who then manages the funds, thereby reducing the influence of industry on selection processes. The policy could be improved by including a section regarding consulting relationships as this is not explicitly mentioned outside of speaking bureaus and research. Besides this, the policy could be further strengthened by not allowing members of the P&T committee who have conflicts of interest to be apart of the decision making process and also with the inclusion of a curriculum on these topics at the medical school and affiliated teaching hospitals.  With the new policy, the Stony Brook's grade has gone from a D to an A.  

 

Demographics: On average students spend 60% of their training at Stony Brook Hospital, 32% at Winthrop University Hospital, and 8% at the Northport VA Medical Center. Submitted policies apply to Stony Brook Hospital and Winthrop University Hospital.

 

* Please note that an evaluation of Stony Brook's policies was performed after the release of the 2011-12 Scorecard.  The changes are noted below.  These changes are unofficial, as they were not performed by our standard double-blinded process.  The policies will be reviewed again by AMSA's typical processes in the fall of 2012.  

 

This institution did not submit any new or additional policies for the 2012-13 AMSA PharmFree Scorecard.

This institution's evaluation was last updated: 7/1/2012



Gifts & Meals 3 Section B and C (Gifts and Food) - Gifts to individual faculty as well as food (which is considered to be personal gifts) are not allowed under any circumstances. Pharmaceutical companies are considered generally disqualified entities from the $75 maximum gift.
Consulting relationships 1 Section F (Participation of Industry Sponsored Programs and Speakers Bureaus) - Faculty are allowed to participate in activities with industry such as speakers' bureaus but are strongly encouraged to have their conflicts fully disclosed and only accept fair market compensation for legitimate services. Agreements between faculty and the company must be submitted to a supervisor in writing and must adhere to CME disclosure policies regardless. It is unclear if these policies apply to consulting relationships as well besides possibly in the section regarding research. A clear policy in regards to consulting would improve the score in this domain.
Industry-funded speaking relationships 3 Section F (Participation of Industry Sponsored Programs and Speakers Bureaus) - Faculty are allowed to participate in activities with industry such as speakers' bureaus but are strongly encouraged to have their conflicts fully disclosed and only accept fair market compensation for legitimate services. Agreements between faculty and the company must be submitted to a supervisor in writing and must adhere to CME disclosure policies regardless. Lecture content is to be determined by the speaker soley and not industry. The speaker is required to provide only objective scientific information and a fair and balanced assessment of therapeutic options.
Disclosure 3 Section J (Teaching) - Faculty are required to publicly disclose using a standardized format at any formal teaching activity and must be done at the beginning. This information will also be entered onto a website. If the disclosure is relevant to the presentation by the faculty member, they must let their supervisor know.
Pharmaceutical samples 3 Section G (Pharmaceutical Samples) - Samples cannot be used without prior approval by the Pharmacy Director and in the outpatient setting, must be approved by the Pharmacy Director. Faculty are not allowed to received samples directly from industry and use for personal use is strictly prohibited. Trainees and attendings are encouraged to be knowledgeable about generic and low cost alternatives.
Purchasing & Formularies 2 The policy reads that individuals that have a direct decision making role in P&T disclose their conflicts of interest prior to the decision. They will not automatically be asked to recuse or be forbidden from serving from the committee but the purchasing unit will decide if this course of action is needed.
Industry Sales Representatives 3 Section A (Pharmaceutical and Device Manufacturer Representatives) - Industry sales reps may interact with faculty but only in non-patient care areas and not anywhere near sites of medical education. The sales rep will be identifiable with a vendor badge and only be allowed on the premise with an advance appointment with a faculty or staff member.
On-campus Education 3 Section D (Support for Other Educational Functions) - The industry funds must be managed by the medical center development office and then disbursed to a department, division, or program. While the policy states that the funds will be going towards an educational event, there is no language about the industry's influence in terms of the content selected to be presented or the speaker.
Attendance at Industry-Sponsored Lectures & Meetings Off-Campus 3 Section E (Travel) - Off-site education must be sponsored by a professional group, not a company. Industry support for travel, meals, and accommodation need to be approved centrally first before being given to the faculty member. Faculty are not allowed to receive direct reimbursement from industry. No dollar limits are set on types of meals or accommodations and there is no langauge regarding gifts or compensation for attending conferences in this policy.
Industry Support for Scholarships & Funds for Trainees 3 Section D (Support for Other Educational Funds) - The SOM department, program or division selects the recipient or tree to which industry support shall go to and will be responsible for the disbursement of funds. There is no expecatation that the recipient need to provide something in return for the support.
Medical school curriculum 1 This policy has no language regarding a medical school curriculum on COI.
Do the policies specify an oversight mechanism? No This policy includes no language regarding oversight.
Are there explicit sanctions for noncompliance? No This policy includes no language regarding sanctions.
What the results mean...
3Model policy
2Good progress toward model policy
1No policy, or policy unlikely to have a substantial effect on behavior
0Did not report
N/APolicy not relevant to this institution (e.g., does not make purchasing decisions)